Vectura Group PLC (VEC) Insider Trevor Phillips Sells 240,841 Shares of Stock
Vectura Group PLC (LON:VEC) insider Trevor Phillips sold 240,841 shares of the business’s stock in a transaction dated Tuesday, September 27th. The shares were sold at an average price of GBX 139 ($1.81), for a total transaction of £334,768.99 ($436,978.19).
Shares of Vectura Group PLC (LON:VEC) opened at 140.70 on Thursday. The stock’s market cap is GBX 952.39 billion. Vectura Group PLC has a 12-month low of GBX 122.90 and a 12-month high of GBX 200.10. The stock’s 50 day moving average is GBX 139.32 and its 200-day moving average is GBX 155.70.
Several equities analysts recently issued reports on the stock. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 230 ($3.00) price target on shares of Vectura Group PLC in a research report on Thursday, July 28th. Peel Hunt reiterated a “buy” rating and set a GBX 200 ($2.61) price target on shares of Vectura Group PLC in a research report on Tuesday, August 30th. FinnCap reiterated a “buy” rating and set a GBX 225 ($2.94) price target on shares of Vectura Group PLC in a research report on Tuesday, August 30th. Numis Securities Ltd boosted their price target on shares of Vectura Group PLC from GBX 246 ($3.21) to GBX 252 ($3.29) and gave the company a “buy” rating in a research report on Monday, September 19th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a GBX 242 ($3.16) price target on shares of Vectura Group PLC in a research report on Friday, July 29th. Eight analysts have rated the stock with a buy rating, Vectura Group PLC currently has a consensus rating of “Buy” and a consensus target price of GBX 222.25 ($2.90).
About Vectura Group PLC
Vectura Group plc is a product development company. The Company focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases (airways diseases). The Company has eight products marketed by its partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies.
Receive News & Stock Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related stocks with our FREE daily email newsletter.